These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 7466260)
21. Efficacy of antenatal steroids. Am J Obstet Gynecol; 1983 Dec; 147(7):851-52. PubMed ID: 6650620 [No Abstract] [Full Text] [Related]
22. Benefit of antenatal glucocorticoids according to the cause of very premature birth. Foix-L'helias L; Baud O; Lenclen R; Kaminski M; Lacaze-Masmonteil T Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F46-8. PubMed ID: 15613573 [TBL] [Abstract][Full Text] [Related]
23. [Critical study of the use of glucocorticoids in the prevention of hyaline membrane disease]. Leroy JL J Gynecol Obstet Biol Reprod (Paris); 1982; 11(1):152-7. PubMed ID: 6896522 [No Abstract] [Full Text] [Related]
24. [Factors increasing susceptibility to neonatal hyaline membrane syndrome and its prevention. I. Deficiency of surfactant and glucocorticoid treatment]. Uszyńska-Folejewska R; Uszyński M Pediatr Pol; 1977 Dec; 52(12):1413-7. PubMed ID: 343058 [No Abstract] [Full Text] [Related]
27. [Prenatal prevention of the respiratory distress syndrome. II. Our experience with betamethasone]. Meriggi E; Parenti MR; Sanlorenzo F Minerva Ginecol; 1980 Mar; 32(3):187-96. PubMed ID: 6892844 [No Abstract] [Full Text] [Related]
28. Why have deaths from respiratory distress syndrome/hyaline membrane disease declined? Another view. Sepkowitz S J Okla State Med Assoc; 1989 Nov; 82(11):570-1. PubMed ID: 2614558 [No Abstract] [Full Text] [Related]
29. [Prenatal membrane syndrome prevention using glucocorticoids]. von Loewenich V; Halberstadt E; Eckert H; Gerner R Monatsschr Kinderheilkd (1902); 1976 May; 124(5):459-60. PubMed ID: 934152 [No Abstract] [Full Text] [Related]
30. [Prevention of the respiratory distress syndrome in the newborn by steroid therapy of the mother before delivery]. Jmre H; Istvan F; Szabolcs S; Karoly M Orv Hetil; 1975 Jan; 116(4):195-6. PubMed ID: 1110834 [No Abstract] [Full Text] [Related]
31. The use of exogenous maternal glucocorticoids to prevent neonatal respiratory distress syndrome (RDS)--the state of the facts. Zachman RD Wis Med J; 1976 Sep; 75(9):S91-2. PubMed ID: 969558 [No Abstract] [Full Text] [Related]
32. The role of perinatal stress and prematurity in the pathogenesis of idiopathic respiratory distress syndrome. Nelson CA J Am Med Womens Assoc; 1968 Oct; 23(10):889-95. PubMed ID: 4247152 [No Abstract] [Full Text] [Related]
33. [Survey on the use of corticoids for the prevention of hyaline membrane disease in France in 1984]. Crimail P; Tribalat S Rev Fr Gynecol Obstet; 1984 Jun; 79(6):477-80. PubMed ID: 6528167 [TBL] [Abstract][Full Text] [Related]
34. [The behaviour of endocrinal parameters under prophylaxis of hyaline membrane disease with glucocorticoids (author's transl)]. Gerner R; Halberstadt E Z Geburtshilfe Perinatol; 1980 Aug; 184(4):262-6. PubMed ID: 6258342 [TBL] [Abstract][Full Text] [Related]
35. [RDS prevention by prednilyden and ambroxol. A comparative study]. Geibel W; Rindt W; Becker H Arch Gynecol; 1979 Jul; 228(1-4):204. PubMed ID: 582652 [No Abstract] [Full Text] [Related]
36. [Induction of fetal lung maturation in the prevention of hyaline membrane disease: the connection with neonatal sepsis]. Driul L; Furlan R; Macagno F; Pezzani I; Plaino L; Ianni A; Casarsa S; Zavarise D; Marchesoni D Minerva Ginecol; 2003 Feb; 55(1):37-42. PubMed ID: 12598841 [TBL] [Abstract][Full Text] [Related]
40. [Characteristics of phospholipids of pharyngeal aspirates in newborn infants depending on the use of glucocorticoids in the prenatal period for the prevention of respiratory disorders]. Kuptsov VA Pediatriia; 1984 Mar; (3):32-4. PubMed ID: 6718156 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]